A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection.
about
Interventions for dialysis patients with hepatitis C virus (HCV) infectionInterferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological ResponseDiagnosis, management, and treatment of hepatitis CInterferon for interferon naive patients with chronic hepatitis C.Hepatitis C virus infection and dialysis: 2012 update.Methodological issues in papers on IFN therapy: time for reappraisal.Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis.Hepatitis C: retreatment and treatment of patients with renal failure.Hepatitis C and kidney disease.Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.HCV in patients with end-stage renal disease.Hepatic disorders in chronic kidney disease.Treatment of hepatitis C virus infection in patients with end-stage renal disease.Hepatitis C infection and chronic renal diseases.When and how can nephrologists treat hepatitis C virus infection in dialysis patients?A six-year follow-up after interferon-alpha monotherapy for chronic hepatitis C infection in hemodialysis patients.Liver steatosis in hepatitis C positive hemodialysis patients and factors affecting IFN-2a treatment.Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update
P2860
Q24187826-1BB0C1A8-CE79-4CA4-B4E8-DB6D3234213AQ27489433-1B4A3937-0AE4-4175-8C26-84D7E720EE8FQ29620656-56E07D60-1B82-474C-9070-998923749A97Q31083635-FDA46B9A-9143-442D-9B38-09C3F1414030Q33710828-F281DC0D-934E-48D3-9C9B-51DB6EC55AF3Q33940500-20B3AF77-0A2F-4C59-930D-0392C4AB31E3Q33969758-1C90DC84-AF78-4213-ADA0-8387581D6824Q33988112-81C44A39-23EE-4285-8A3F-58DA70BC387AQ34415087-176E513A-4089-4D15-AD14-4844CB6EB8A2Q35599599-7F3E374F-1A1A-4365-8385-1E19CCD40E81Q37150375-FAD5BCCF-5E81-4DDE-9F34-798F98FC29A7Q37270836-0920476C-AAB6-44A6-A305-52742098A811Q37729824-9D0BDF0A-1DA2-4618-B2A4-5EED082AD2E4Q37831965-035EB47F-7D01-4D01-B8DD-B7560E36241AQ38552198-3F5E6130-AFC8-4F1F-8E70-9586830E4EBFQ41934901-A2F0BAED-53C5-4081-A644-E16F71173C58Q45139527-8B0D40B3-9A6F-44EE-B4D8-22CE88B2159CQ53699180-A433F7AC-B578-4CC8-BCEF-9C3CB3F1DB7EQ58622847-D0DFF487-BA46-4BAB-8548-A2FB2E0F70C6
P2860
A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
A double-blind controlled tria ...... or the Study of HCV infection.
@en
A double-blind controlled tria ...... or the Study of HCV infection.
@nl
type
label
A double-blind controlled tria ...... or the Study of HCV infection.
@en
A double-blind controlled tria ...... or the Study of HCV infection.
@nl
prefLabel
A double-blind controlled tria ...... or the Study of HCV infection.
@en
A double-blind controlled tria ...... or the Study of HCV infection.
@nl
P2093
P1476
A double-blind controlled tria ...... or the Study of HCV infection.
@en
P2093
P304
P356
10.1111/J.1365-2893.1997.TB00213.X
P577
1997-03-01T00:00:00Z